Journal Logo

EVALUATION OF COMBINED MEASUREMENT OF IMMATURE PLATELET FRACTION AND SCHISTOCYTES IN PREGNANCY-ASSOCIATED THROMBOTIC THROMBOCYTOPENIC PURPURA AND SEVERE PREECLAMPSIA/ HELLP SYNDROME

PS1478

Fayek, M.1; Mekawy, M.2; El-Gamal, R.2; Abdelkader, A.3; Abdelbary, H.4

doi: 10.1097/01.HS9.0000564176.35943.6f
Poster Session II: Platelets disorders
Free

1Clinical Pathology, Misr University for Science and Technology

2Clinical Pathology Department

3Obstetrics and Gynecology Department, Ain Shams University

4Clinical Hematology and Bone Marrow Transplantation Unit, Ain Shams University Hospital, Cairo, Egypt

Back to Top | Article Outline

Background:

The occurrence of thrombotic microangiopathy (TMA) in pregnancy is an unfortunate emergency condition. Proper diagnosis is mandatory which requires the consideration of two overlapping diagnoses: severe preeclampsia/ haemolysis, elevated liver enzymes, and low platelet syndrome (SPE/HELLP) and thrombotic thrombocytopenic purpura (TTP). The long turn-around times of ADAMTS13 testing precludes the timely distinction between the two conditions.

Back to Top | Article Outline

Aims:

We aimed at evaluating schistocyte counts and immature platelet fraction (IPF%), as both increase in TMAs, to discriminate between TTP and SPE/HELLP of pregnancy.

Back to Top | Article Outline

Methods:

IPF% was measured using SysmexXE-2100 automated hematology analyzer, and schistocyte counts were estimated microscopically as per the International Council for Standardization in Hematology (ICSH)-Schistocyte Working Group guidelines. The study included 30 pregnant patients with SPE/HELLP, 13 pregnant patients with TTP, and 30 women with normal pregnancy. The discrimination between the two patient categories was based on clinical judgment and TTP cases were identified using the PLASMIC score.

Back to Top | Article Outline

Results:

TTP patients had higher values of IPF% than SPE/HELLP 19.5 (16.9-27.1) vs 13 (9.5 - 23.25); p <0.001); similar results were revealed regarding schistocyte counts 6.5 (3.9-8.6) vs 2.1 (1.6 - 3.5); p <0.001). IPF% and schistocyte counts were able to discriminate between TMA patients and normal pregnant women, and between and SPE/HELLP and TTP patients. Moreover, the discriminatory function of each was improved when the two parameters were used in combination.

Back to Top | Article Outline

Summary/Conclusion:

IPF% analysis should be used in conjunction with manual schistocyte counting in TMA cases to distinguish TTP pregnant patients from patients having SPE/HELLP.

Copyright © 2019 The Authors. Published by Wolters Kluwer Health Inc., on behalf of the European Hematology Association.